Search

Search Constraints

You searched for: Author/Creator Rettig, Matthew

Search Results

1. 340 Phase 1 study of AMG 160, a half-life extended BiTE® (bispecific T-cell engager) therapy targeting prostate-specific membrane antigen, in patients with metastatic castration-resistant prostate cancer. (10th December 2020)

2. Discord Among Radiation Oncologists and Urologists in the Postoperative Management of High-Risk Prostate Cancer. (August 2018)

4. High‐Purity Prostate Circulating Tumor Cell Isolation by a Polymer Nanofiber‐Embedded Microchip for Whole Exome Sequencing. (26th March 2013)

5. PD35-04 QUANTITATIVE PIFLUFOLASTAT F18 (PSMA) SCAN INDICES AS A RESPONSE IMAGING-BIOMARKER TO ANDROGEN DEPRIVATION THERAPY IN VETERANS WITH NEWLY DIAGNOSED METASTATIC PROSTATE CANCER. (1st May 2022)

8. Tumor Cell Isolation: High‐Purity Prostate Circulating Tumor Cell Isolation by a Polymer Nanofiber‐Embedded Microchip for Whole Exome Sequencing (Adv. Mater. 21/2013). (4th June 2013)